ADC Review, Journal of Antibody-drug Conjugates Advisory Board is comprised of physicians, industry experts and Key Opinion Leaders (KOL) from a broad range of backgrounds and expertise that include:
- Clinical oncology and hematology practice innovation, management, public policy, professional advocacy and education.
- Actively managing successful clinical practices, teaching at major universities and hospitals, holding senior management positions at medical associations, research institutes / laboratories, pharmaceutical and life-science companies, governmental agencies and major insurance companies.
- Impressive level of healthcare experience, enabling us to offer innovation, education, advocacy and best practices to our readers.
To join our advisory board, please contact:
Peter Hofland
Publisher and Executive Editor
[email protected]
